Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -54.92% vs -17.97% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -48.74% vs -21.77% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -16.67% vs 200.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Viridian Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -15.88% vs -34.52% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -54.92% vs -17.97% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -13.90% vs -7.10% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -48.74% vs -21.77% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -16.67% vs -33.33% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -16.67% vs 200.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






